Pioglitazone

Hmm… We’d better think about this again. Pioglitazone is not a good first‑line choice because it causes weight gain and fluid retention and it lacks clear cardiovascular outcome benefits. If a thiazolidinedione is considered at all, it is considered in cases where first line drugs are not indicated or unavailable, or in combination with other first line drugs.

Try to think about other drugs with favourable weight and cardiovascular profiles. Always consider the full clinical context when prescribing medications and try again!

  • 2 [undo]
  • Glyceryl trinitrate [undo]
  • Misses her follow up visit to the doctor [undo]
  • CULTURA ȘI CREȘTEREA MICROBIANĂ [undo]
  • Ramipril (ACE inhibitor) [undo]
  • ΚΥΤΤΑΡΙΚΗ ΔΙΑΙΡΕΣΗ [undo]
  • Ask Pertinent Negatives (TB Status & Other) [undo]
  • Digoxin [undo]
  • History of Present Illness [undo]
  • Remote Physical Examination (Guided) [undo]
  • Προτείνεις να δώσεις χρήματα από τον κουμπαρά σου. [undo]
  • Ξεκινά έντονη προπόνηση [undo]
  • Root Node [undo]
  • High Molecular Weight Heparin [undo]
  • IDENTIFICATION OF BIOMOLECULES [undo]
  • [undo]
  • Karyotype Results [undo]
  • Give paracetamol, observe for 6 hours then review [undo]
  • Ατομικό ιστορικό [undo]
  • Pioglitazone [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21091
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway